Going beyond boundaries in structural heart interventions?
Chairpersons: M.B. Leon, F. Maisano, A. Vahanian
Objectives:
To gain perspective from thought leaders on how the cathlab will evolve over the next 5-10 yearsTo participate to a unique discussion on the evolution of structural heart interventions
To learn the preferred strategy for combined cardiac diseases: while a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients
Lectures
Session objectives
A. Vahanian
What is structural heart intervention today?
M.B. Leon
How will TAVI technologies evolve over the next 5-10 years?
A. Linke
Transcatheter mitral valve replacement and repair: are new realities on the TMVR horizon?
R. S. Von Bardeleben
Transcatheter tricuspid valve interventions in 2017: unmet needs and future perspectives
J. Hausleiter
Case 1 - Mitral regurgitation and atrial fibrillation
F. Nietlispach
Case 2 - Bivalvular disesase: mitral and tricuspid regurgitation
J. Hausleiter
Case 3 - Bivalvular disesase: aortic stenosis and mitral regurgitation
C. Tamburino
Structural heart disease: glimpse into the future
F. Maisano